Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1Phase 1 1

Status

Active not recruiting 4Recruiting 1

Sponsor Class

NIH 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Rectal Neoplasms 3Anus Neoplasms 2HIV Infections 1Colorectal Neoplasms 1Colonic Neoplasms 1Anal Canal Carcinoma 1Adenomatous Polyposis Coli 1

Interventions

Oxaliplatin 135Fluorouracil 129Gemcitabine 114Bevacizumab 111Specimen Handling 101Leucovorin 101Capecitabine 87Magnetic Resonance Spectroscopy 81pembrolizumab 78Cisplatin 74Nivolumab 70Irinotecan 68Cetuximab 58130-nm albumin-bound paclitaxel 58durvalumab 57Paclitaxel 57Biopsy 55atezolizumab 42Radiotherapy 40Albumin-Bound Paclitaxel 36Taxes 35Folfox protocol 34Carboplatin 34Drug Therapy 28lenvatinib 27sintilimab 26dehydroftorafur 26Radiation 26Cyclophosphamide 26tislelizumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Sigmoidoscopy × Gastrointestinal × 90 days × Clear all
NCT03233711 2026-05-29

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
344 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT04751370 2026-05-29

Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
31 enrolled
Gastrointestinal

Rectal Neoplasms

NCT04929028 2026-05-13

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
40 enrolled
Gastrointestinal

Anus Neoplasms, Rectal Neoplasms, HIV Infections

NCT05630794 2026-05-13

Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

National Cancer Institute (NCI)

Phase 1 Recruiting
36 enrolled
Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT01696981 2026-04-30

Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial)

National Cancer Institute (NCI)

Phase NA Active not recruiting
154,900 enrolled 15 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡